Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies

National Resilience, Inc. (Resilience) and bluebird bio, Inc. (NASDAQ: BLUE), today announced a strategic alliance aimed to accelerate the early research, development and delivery of cell therapies.